Clinical Trials Sponsored by Altor Bioscience Corporation
Total 71 results
-
Altor BioScienceTerminatedRelapsed/Refractory Indolent B Cell Non-Hodgkin LymphomaUnited States
-
Altor BioScienceCompletedProgressive Metastatic MalignanciesUnited States
-
Altor BioScienceCompletedHealthyUnited States
-
Altor BioScienceTerminatedPharmacokineticsUnited States
-
Altor BioScienceCompletedAdvanced Pancreatic CancerUnited States
-
Altor BioScienceCompletedMalignant Solid Tumour | Locally Advanced Malignant NeoplasmUnited States
-
Altor BioScienceGenentech, Inc.; TanoxCompletedSepsis | Acute Respiratory Distress Syndrome | Acute Lung InjuryUnited States, Canada
-
Altor BioScienceNational Cancer Institute (NCI)CompletedAdvanced Solid TumorsUnited States
-
Altor BioScienceNational Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Altor BioScienceNational Cancer Institute (NCI)UnknownTransitional Cell Carcinoma of Bladder | Urethra Cancer | Ureter Cancer | Malignant Tumor of Renal PelvisUnited States
-
Altor BioScienceNational Cancer Institute (NCI)UnknownRelapsed or Refractory Multiple MyelomaUnited States
-
Altor BioScienceNational Cancer Institute (NCI)TerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Altor BioScienceM.D. Anderson Cancer CenterWithdrawnAcute Myeloid LeukemiaUnited States
-
Graviton Bioscience CorporationCompleted
-
Medical University of South CarolinaAltor BioScienceCompletedNon-small Cell Lung CancerUnited States
-
Venn Biosciences CorporationActive, not recruitingColorectal CancerUnited States
-
University of ArkansasBristol-Myers Squibb; Altor BioScienceWithdrawnMultiple MyelomaUnited States
-
Venn Biosciences CorporationActive, not recruitingOvarian Cancer | Adnexal Mass | Pelvic MassPhilippines, United States, Malaysia, Australia
-
Alliancells Bioscience Corporation LimitedUnknownLiver CirrhosisChina
-
Alliancells Bioscience Corporation LimitedUnknownRheumatoid ArthritisChina
-
Altor BioScienceJames and Esther King Biomedical Research ProgramUnknownNon-muscle Invasive Bladder CancerUnited States
-
Altor BioScienceNational Heart, Lung, and Blood Institute (NHLBI)CompletedSepsis | Acute Respiratory Distress Syndrome | Acute Lung InjuryUnited States
-
Perle Bioscience, Inc.Syreon CorporationWithdrawn
-
iScience Interventional CorporationCompleted
-
Incyte BioSciences FranceCompletedChronic Myeloid LeukemiaFrance
-
Incyte Biosciences BeneluxCompletedChronic Myeloid Leukemia | CML | Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | Ph+ ALLBelgium
-
Assembly BiosciencesArbutus Biopharma CorporationTerminatedChronic Hepatitis BAustralia, Canada, Bulgaria, New Zealand
-
Incyte Biosciences UKCompletedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | Blastic Phase Chronic Myelogenous LeukemiaUnited Kingdom, Ireland
-
Dana-Farber Cancer InstituteBristol-Myers Squibb; Altor BioScience; Miltenyi Biomedicine GmbHRecruitingSquamous Cell Carcinoma of the Head and Neck | Recurrent Head and Neck Squamous Cell CarcinomaUnited States
-
Incyte Biosciences Japan GKNot yet recruiting
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
Incyte Biosciences International SàrlRecruitingLymphoma | Acute Myeloid Leukemia | Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Solid Tumors | Chronic Phase Chronic Myeloid Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blast Phase Chronic Myeloid LeukemiaSpain, Italy, France, Germany, United Kingdom, Belgium, Sweden, Denmark, Netherlands
-
Incyte Biosciences International SàrlWithdrawnRecurrent Head and Neck Squamous Cell Carcinoma | Advanced Malignancies | Metastatic Head and Neck Squamous Cell CarcinomaUnited States
-
Qure Healthcare, LLCVenn Biosciences CorporationWithdrawnNon Small Cell Lung Cancer
-
Incyte Biosciences Japan GKCompletedAdvanced Solid Tumors | Metastatic Solid TumorsJapan
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, Belgium, Australia, Spain
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States, United Kingdom, Spain, Switzerland
-
Incyte Biosciences Japan GKCompleted
-
Incyte Biosciences Japan GKTerminated
-
Incyte Biosciences Japan GKCompletedHealthy ParticipantsJapan
-
Incyte Biosciences International SàrlCompletedMetastatic Cancer | Advanced MalignanciesUnited States
-
Incyte Biosciences Japan GKRecruitingDiffuse Large B-cell Lymphoma | Non Hodgkins LymphomaJapan
-
Incyte Biosciences International SàrlCompletedAdvanced MalignanciesUnited States
-
Incyte Biosciences International SàrlTerminatedMetastatic Cancer | Advanced MalignanciesUnited States
-
Incyte Biosciences International SàrlCompletedCervical Cancer | Hepatocellular Carcinoma | Esophageal Cancer | Ovarian Cancer | Mesothelioma | Non-small Cell Lung Cancer (NSCLC) | Urothelial Carcinoma | Merkel Cell Carcinoma | Diffuse Large B-cell Lymphoma | Triple-negative Breast Cancer | Renal Cell Carcinoma (RCC) | Small Cell Lung Cancer (SCLC) | Squamous... and other conditionsUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States, France, Italy, United Kingdom
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Daiichi Sankyo, Inc.Ambit Biosciences CorporationCompletedLeukemia, Myeloid, AcuteUnited States
-
Incyte Biosciences International SàrlWithdrawnBCR-ABL Positive Acute Lymphoblastic LeukemiaGermany, France, Czechia
-
Ottawa Heart Institute Research CorporationSpartan Bioscience Inc.Completed